SILO PHARMA INC. - COMMON STOCK
0.8600
22-11月-24 16:44:58
15 分の遅延
株式
-0.0500
-5.49%
本日の幅
0.8300 - 0.9878
ISIN
N/A
ソース
NASDAQ
-
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
18 11 2024 08:40:00 提供 Nasdaq GlobeNewswire
-
31 10 2024 08:35:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 06:35:00 提供 Nasdaq GlobeNewswire
-
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
14 8 2024 14:30:00 提供 Nasdaq GlobeNewswire
-
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
07 8 2024 08:13:00 提供 Nasdaq GlobeNewswire
-
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
26 7 2024 08:20:00 提供 Nasdaq GlobeNewswire
-
22 7 2024 16:45:00 提供 Nasdaq GlobeNewswire
-
19 7 2024 08:01:00 提供 Nasdaq GlobeNewswire
-
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
18 7 2024 08:25:00 提供 Nasdaq GlobeNewswire
-
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
16 7 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
IBN (InvestorBrandNetwork) Coverage Initiated for Silo Pharma Inc.
30 3 2022 08:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >